Inhibition of NLRP3 or caspase-1 inflammasome activation, thereby inhibiting renal inflammation and fibrosis (at least in part), via suppression of oxidative stress in DN imparts protective effects on the kidney (97–99). The gene discussed is CASP1; the disease is liver dysplastic nodule.